Anika Therapeutics Pain Management Sales Offset COVID Surgical Declines

By Mike Evers

Anika Therapeutics Pain Management Sales Offset COVID Surgical Declines
The company grew almost 24% in 3Q21 due in large part to order timing from its strategic viscosupplement sales partners, including J&J Mitek.

Member-Only Content

SUBSCRIBE Login

Product Labels: Orthobiologic Soft Tissue Repair, Finger/Hand/Wrist Replacement, Viscosupplement

Tags: Revenue Report